In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CFY Biomedicals Inc.

Latest From CFY Biomedicals Inc.

Antibody Opportunities

Antibodies are driving valuations at many public companies--and the aspirations of start-ups with new means of generating, tailoring and harnessing the proteins.
BioPharmaceutical Strategy

CFY Biomedicals Inc.

San Diego-based CFY Biomedicals Inc. believes it has the technological wherewithal to create a cure and/or preventive for the common cold. It's betting on antibody-based products that block the receptor which most forms of human rhinovirus (HRV) use to enter and infect nasal epithelial cells.
BioPharmaceutical Research and Development Strategies

Start-Up Previews (09/00)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Neurodegenerative Disorders, features profiles of Active Pass Pharmaceuticals Inc., Aegera Therapeutics Inc., Panacea Pharmaceuticals Inc. and Proteotech Inc. Plus these selected Start-Ups across Health Care: Amicas Inc., CFY Biomedicals Inc., MDISource and Visco Technologies Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CFY Biomedicals Inc.
  • Senior Management
  • Mang Yu, PhD, VP
    John Reno, PhD, Pres.
  • Contact Info
  • CFY Biomedicals Inc.
    Phone: (858) 622-0400
    6310 Nancy Ridge Dr., Suite 102
    San Diego, CA 92121